SLC43A2
Large neutral amino acids transporter small subunit 4
Also known as: LAT4_HUMAN, MGC34680
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N370
- Gene
- SLC43A2
- Ensembl
- ENSG00000167703
- Chromosome
- 17
- Canonical length
- 569 aa
- Protein class
- Metabolic proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
This gene encodes a member of the L-amino acid transporter-3 or SLC43 family of transporters. The encoded protein mediates sodium-, chloride-, and pH-independent transport of L-isomers of neutral amino acids, including leucine, phenylalanine, valine and methionine. This protein may contribute to the transfer of amino acids across the placental membrane to the fetus. [provided by RefSeq, Mar 2016]
Canonical amino-acid sequenceUniProt
569 residues, UniProt reviewed canonical sequence.
>Q8N370|SLC43A2
1 MAPTLATAHR RRWWMACTAV LENLLFSAVL LGWGSLLIML KSEGFYSYLC TEPENVTNGT
61 VGGTAEPGHE EVSWMNGWLS CQAQDEMLNL AFTVGSFLLS AITLPLGIVM DKYGPRKLRL
121 LGSACFAVSC LLIAYGASKP NALSVLIFIA LALNGFGGMC MTFTSLTLPN MFGDLRSTFI
181 ALMIGSYASS AVTFPGIKLI YDAGVSFIVV LVVWAGCSGL VFLNCFFNWP LEPFPGPEDM
241 DYSVKIKFSW LGFDHKITGK QFYKQVTTVG RRLSVGSSMR SAKEQVALQE GHKLCLSTVD
301 LEVKCQPDAA VAPSFMHSVF SPILLLSLVT MCVTQLRLIF YMGAMNNILK FLVSGDQKTV
361 GLYTSIFGVL QLLCLLTAPV IGYIMDWRLK ECEDASEEPE EKDANQGEKK KKKRDRQIQK
421 ITNAMRAFAF TNLLLVGFGV TCLIPNLPLQ ILSFILHTIV RGFIHSAVGG LYAAVYPSTQ
481 FGSLTGLQSL ISALFALLQQ PLFLAMMGPL QGDPLWVNVG LLLLSLLGFC LPLYLICYRR
541 QLERQLQQRQ EDDKLFLKIN GSSNQEAFVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC43A2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 12
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 55 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 55 nTPM
- kidney: 37 nTPM
- spleen: 29 nTPM
- placenta: 21 nTPM
- lung: 21 nTPM
- cerebellum: 19 nTPM
Single-cell type
- renal collecting duct intercalated cells: 395 nCPM
- proximal tubule cells: 181 nCPM
- loop of henle epithelial cells: 144 nCPM
- renal connecting tubule cells: 121 nCPM
- distal convoluted tubule cells: 108 nCPM
- syncytiotrophoblasts: 102 nCPM
Immune cell
- neutrophil: 16 nTPM
- classical monocyte: 6.5 nTPM
- eosinophil: 6.1 nTPM
- non-classical monocyte: 5.2 nTPM
- intermediate monocyte: 4.9 nTPM
- myeloid DC: 3.4 nTPM
Brain region
- medulla oblongata: 28 nTPM
- pons: 26 nTPM
- thalamus: 24 nTPM
- cerebral cortex: 18 nTPM
- cerebellum: 17 nTPM
- hypothalamus: 17 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.57
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 1.8
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- amino acid transport
- isoleucine transport
- L-leucine transport
- methionine transport
- negative regulation of amino acid transport
- negative regulation of L-leucine import across plasma membrane
- neutral amino acid transport
- phenylalanine transport
Molecular functions
- amino acid transmembrane transporter activity
- L-amino acid transmembrane transporter activity
- L-isoleucine transmembrane transporter activity
- L-leucine transmembrane transporter activity
- L-phenylalanine transmembrane transporter activity
- neutral L-amino acid transmembrane transporter activity
- L-methionine transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC43A2 as an antibody target. Whether an autoantibody or antibody against SLC43A2 could matter depends on whether native SLC43A2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC43A2 is annotated at the cell surface, where native SLC43A2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC43A2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...